Trials / Completed
CompletedNCT00748059
The Pathophysiology of Orthostatic Hypotension
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 12 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the cause of low blood pressure in selective patients who have problems with their involuntary (autonomic) nervous system. These patients frequently have had symptoms throughout their life, and their disorder might have a genetic basis. The biochemical, physiological and pharmacological procedures in this study should help us define the problem and perhaps lead to more effective treatment.
Conditions
- Autonomic Nervous System Diseases
- Orthostatic Hypotension
- Dopamine Beta-Hydroxylase Deficiency
- Orthostatic Intolerance
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Standing or upright tilt | stand upright or tilt table test |
| PROCEDURE | Microneurography | Recording from sympathetic nerve |
| PROCEDURE | QSweat | quantitative sweat testing |
| DEVICE | neck cuff stimulation | Blood pressure receptors in the neck arteries may be stimulated by applying suction through a collar around the neck. |
| DRUG | phenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramine | IV Pharmacological Testing phenylephrine 12.5 - 400 ug, isoproterenol 0.1 - 0.4 ug or higher until desired effect, nitroprusside 0.1 - 1.6 ug/kg, propranolol 1.1 mg/min, edrophonium maximum of 10 mg, atropine .01 mg/kg, tyramine 250-4000 ug or higher until desired effect |
| DRUG | clonidine,yohimbine,metoclopramide,alpha-methyldopa | Oral Pharmacological Testing clonidine 0.1-0.3 mg, yohimbine 5-10 mg, metoclopramide 10 mg, alpha-methyldopa 62.5 mg, placebo |
| PROCEDURE | BodPod | Determination of body composition |
| PROCEDURE | Eye exam | Examination of pressure in the eye and eyelid fatiguability. The following eyedrops might be used: 1. 0.5% proparacaine (Alcaine, Allergan, Inc) 2. Fluress (0.4% benoxinate hydrochloride, fluorescein sodium, Akorn, Inc) 3. 0.5%, 1% tropicamide (Mydriacyl, Alcon) 4. Over-the-counter preservative-free artificial tears 5. 0.25%, 2.5% and 10% phenylephrine (Bausch and Lomb) 6. 1% cyclopentolate hydrochloride (Alcon) |
| PROCEDURE | Sleep study | Recording of sleep pattern overnight |
| PROCEDURE | Pain response testing | Subjects will rate the quality and intensity of 2 pain tasks. |
| PROCEDURE | Metabolic chamber | Determination of metabolic rate via 24hr stay in whole-room indirect calorimeter |
| PROCEDURE | Brain function studies | Questionnaires and computer tasks, an EEG and an MRI may be used to assess brain function. |
| PROCEDURE | Bicycle Exercise Test | Blood pressure and heart rate may be monitored while exercising on a stationary bicycle. |
Timeline
- Start date
- 1996-12-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2008-09-08
- Last updated
- 2021-05-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00748059. Inclusion in this directory is not an endorsement.